Abstract:Background It is unknown if CRT would improve or halt the progression of heart failure (HF) in patients with mild-moderately reduced LVEF (HFmmrEF) and LBBB. Objective To investigate the outcomes of CRT in patients with HFmmrEF and LV conduction delay. Methods A prospective, randomized clinical trial sponsored by NHLBI included 76 patients who met the study inclusion criteria (LVEF 36-50% and LBBB). Patients received CRTP and were randomized to CRT-OFF (RV pacing 40bpm) or CRT-ON (BIV pacing 60-150bpm). At a 6-month follow-up, pacing programming was changed to the opposite settings. NYHA class, NT pro-BNP levels, and echocardiography were collected at baseline, 6-month, and 12-month. The primary study endpoint was the LV end-systolic volume (LVESV) change from baseline, and the primary randomized comparison was the comparison of 6-month to 12-month changes between randomized groups. Results The mean patient age was 68.4±9.8 years (male 71%). Baseline characteristics were similar between 2 randomized groups (all P>0.05). In patients randomized to CRT-OFF first, then ON, LVESV was reduced from baseline only after CRT-ON (baseline 116.1±36.5 mL, CRT-ON 87.6±26.0 mL, P<0.0001). The randomized analysis of LVEF showed a significantly better change from 6 to 12 months in the "OFF-ON" group, P=0.003. LVEF was improved by CRT (baseline 41.3±4.7%, CRT-ON 46.0±8.0%, P=0.002). In patients randomized to CRT-ON first, then OFF, LVESV was reduced both after CRT-ON and CRT-OFF (baseline 109.8±23.5 mL, CRT-ON 91.7±30.5 mL, P<0.0001; CRT-OFF 99.3±28.9 mL, P=0.012). However, the LVESV reduction effect became smaller between CRT-ON and OFF (P=0.027). LVEF improved both after CRT-ON and CRT-OFF (baseline 42.7±4.3%, CRT-ON 48.5±8.6%, P<0.001; CRT-OFF 45.9±7.7%, P=0.025). Conclusion CRT for patients with HFmmrEF significantly improves LVEF and ventricular remodeling after 6 months of CRT. The study provides novel evidence that early CRT benefits patients with HFmmrEF with LBBB.

Comparison of the outcome between patients with new-onset atrial fibrillation and patients retained sinus rhythm after cardiac resynchronization therapy

Clinical Effect of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure

Efficacy of cardiac resynchronization therapy in chronic heart failure patients with persistent atrial fibrillation

A comparison different rate-control in patients with heart failure and atrial fibrillation underwent resynchronization therapy

The clinical response of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation

[Factors Associated with the Efficacy of Cardiac Resynchronization Therapy in Patients with Chronic Heart Failure].

The effects of cardiac resynchronization and pharmacological treatment to control ventricular rate in chronic heart failure patients and coexistent persistent atrial fibrillation

Effects of Cardiac Resynchronization Therapy on Incidence of Atrial Fibrillation in Patients With Poor Left Ventricular Systolic Function

Predictors for Cardiac Resynchronization Therapy Response

Improvement of Atrial Function and Atrial Reverse Remodeling after Cardiac Resynchronization Therapy for Heart Failure

Improvement of left atrial function is associated with lower incidence of atrial fibrillation and mortality after cardiac resynchronization therapy

Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation

[Factors Associated with Efficacy of Cardiac Resynchronization Therapy for Patients with Congestive Heart Failure].

Initial Experiences of Maintaining Atrioventricular Intrinsic Conduction During Cardiac Resynchronization Therapy in Non-Responders.

Long term therapeutic effect of cardiac resynchronization therapy on patients with congestive heart failure

Cardiac Resynchronization Therapy for Patients with Mild to Moderately Reduced Ejection Fraction and Left Bundle Branch Block

Efficacy of Cardiac Resynchronization Therapy for Patients with Refractory Congestive Heart Failure

Clinical Observation of Resynchronization Therapy for Patients with Chronic Heart Failure

Long-term effects of cardiac resynchronization therapy in patients with congestive heart failure

A pilot study to assess benefit of atrial rhythm control after cardiac resynchronization therapy and atrioventricular node ablation

A conversion CRT strategy combined with AVJA may be a perspective alternative for heart failure patients with persistent atrial fibrillation